tretinoin and Skin-Diseases--Bacterial

tretinoin has been researched along with Skin-Diseases--Bacterial* in 1 studies

Other Studies

1 other study(ies) available for tretinoin and Skin-Diseases--Bacterial

Article	Year
Use of all-trans retinoic acid to treat acute promyelocytic leukemia: a case with very severe features at the onset in Nicaragua. Medical and pediatric oncology, 1996, Volume: 26, Issue:4 We observed a child with acute promyelocytic leukemia (APL) who, at the onset, had extremely severe hemorrhagic and septic complications. According to our experience in Nicaragua, there was a very high risk of early death. The patient was successfully treated with a program that included all-trans retinoic acid (ATRA) followed by cytotoxic chemotherapy. ATRA has two important features: it is effective in initial treatment of APL and it is inexpensive. Because of the high cost and the need for extensive supportive care, optimal myeloablative therapy used in patients with various types of acute myeloid leukemia generally cannot be given in developing countries. ATRA treatment for APL is affordable everywhere. Topics: Antineoplastic Agents; Bacteremia; Child; Developing Countries; Drug Costs; Female; Hemorrhage; Humans; Leukemia, Promyelocytic, Acute; Nicaragua; Pseudomonas aeruginosa; Pseudomonas Infections; Remission Induction; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Tretinoin	1996

Article

Year

Use of all-trans retinoic acid to treat acute promyelocytic leukemia: a case with very severe features at the onset in Nicaragua.

Medical and pediatric oncology, 1996, Volume: 26, Issue:4

We observed a child with acute promyelocytic leukemia (APL) who, at the onset, had extremely severe hemorrhagic and septic complications. According to our experience in Nicaragua, there was a very high risk of early death. The patient was successfully treated with a program that included all-trans retinoic acid (ATRA) followed by cytotoxic chemotherapy. ATRA has two important features: it is effective in initial treatment of APL and it is inexpensive. Because of the high cost and the need for extensive supportive care, optimal myeloablative therapy used in patients with various types of acute myeloid leukemia generally cannot be given in developing countries. ATRA treatment for APL is affordable everywhere.

Topics: Antineoplastic Agents; Bacteremia; Child; Developing Countries; Drug Costs; Female; Hemorrhage; Humans; Leukemia, Promyelocytic, Acute; Nicaragua; Pseudomonas aeruginosa; Pseudomonas Infections; Remission Induction; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Tretinoin

1996